Thermosome (Biopharma, Biotechnology) — Funding, Investors & Signals 2026

Thermosome

Re-inventing tumor targeting

Founded 2015 Germany

Planegg, Germany 7 employees Grant Biopharma, Biotechnology

Thermosome is a clinical-stage drug development company focused on targeted tumor therapy combined with immune stimulation for improved cancer therapy. At its core is a novel, proprietary tumor targeting approach that allows for significantly increased local drug concentrations and improved tumor penetration to achieve improved clinical treatment efficacy. Thermosome’s lead drug candidate THE001 is a thermosensitive liposomal formulation of the chemotherapeutic drug doxorubicin (DPPG2-TSL-DOX). It has a different mode of action than conventional liposomes. Thermosome's technology enables intravascular drug release initiated by a mild heat trigger using clinically established hyperthermia devices. This results in an up to 15-fold higher local drug concentrations in the tumor and aims to improve clinical treatment efficacy by creating a local boost at the desired site of action. The first clinical indication for its lead drug candidate THE001 is soft tissue sarcoma, where the company aims to improve the current standard of care (free doxorubicin). Thermosome´s approach enables targeted tumor treatment independent of specific molecular targets and covers patient populations across all tumor subtypes. THE001 has further development potential in other anthracycline-sensitive solid tumors, such as breast cancer, bladder cancer or ovarian carcinoma. Founded in 2015, Thermosome is headquartered in Germany. With an innovative approach and promising lead drug candidate, Thermosome presents a compelling opportunity for potential investors in the Biopharma and Biotechnology industries.

FAQ About Thermosome

Re-inventing tumor targeting

Thermosome was founded in 2015.

Thermosome is headquartered in Planegg, Germany.

Thermosome operates in the following industries: Biopharma, Biotechnology.

Thermosome has approximately 7 employees.

Top alternatives and competitors to Thermosome include Genprex, Inc., Cybrexa Therapeutics, Microbion Corporation, Nanobiotix, Hepion Pharmaceuticals. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.

Thermosome and Genprex, Inc. are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Thermosome

General Information

Track Thermosome

Discover More

About Thermosome

Thermosome Alternatives & Competitors

FAQ About Thermosome

Don't just browse. Track.